NHS child puberty blocker trial SUSPENDED after medicines regulator raises new concerns

The National Health Service s puberty blocker trial for children has been suspended after Britain s medicines regulator raised fresh safety concerns. The preliminary work to establish the Government backed PATHWAYS trial has been paused following new advice from the Medicines and Healthcare products Regulatory Agency (MHRA). It has written to King s College London, which is sponsoring the trial, outlining specific issues that must be addressed before the study can proceed

0 views
Share:
NHS child puberty blocker trial SUSPENDED after medicines regulator raises new concerns

The National Health Service s puberty blocker trial for children has been suspended after Britain s medicines regulator raised fresh safety concerns. The preliminary work to establish the Government backed PATHWAYS trial has been paused following new advice from the Medicines and Healthcare products Regulatory Agency (MHRA). It has written to King s College London, which is sponsoring the trial, outlining specific issues that must be addressed before the study can proceed

Tags

aitechnologypoliticsscienceworldcryptochildpubertyblockertrialsuspended